Geode Therapeutics is a stealth-mode biotech company whose aim is to develop cutting edge treatments in cancer and conditions related to cancer. Their goal is to develop next-generation kinase modulators using proprietary, artificial intelligence-powered platforms to advance their discovery efforts. Their team is founded and led by scientists driven to discover best-in-class therapeutics for cancer treatment that will make a real difference to patients. Geode Therapeutics has raised a total of $5.3M in funding.